https://charts.traderzeitung.de/phases/US6412881053
string(1365) "{"isin":"US6412881053","name":"NeuroPace Inc","stock_id":20512090,"generated_at":"2026-10-22 04:49:00","days":[{"date":"2026-10-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":12.77,"close_at":"2026-10-19 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":13.48,"close_at":"2026-10-20 21:59:00","complete":true,"perf_pct":5.5599},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":13.07,"close_at":"2026-10-21 21:58:00","complete":true,"perf_pct":-3.0415},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Neuropace Aktie News & Nachrichten
Trading-Room

Neuropace Aktie News & Nachrichten

[WKN: A3CM06 | Symbol: NPCE]
Realtimekurs
   
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Neuropace

NeuroPace: Neurostimulator gegen Epilepsie bietet Umsatzchance von 3,5 Mrd. USD!

Das Medizintechnikunternehmen NeuoPace (NPCE) hat sich mit implantierbaren Neurostimulatoren auf die...

TOP-5-Kursziele der Analysten am 21.01.25

Rocket Lab USA [US7731221062]: Citigroup bekräftigt Buy-Rating und erhöht das Kursziel von 22 auf 35...

  • ‹
  • 1
  • ›
Neuropace Nachrichtenticker öffnen
MT Newswires 18.09.2026 12:39 Uhr

KeyBanc nimmt NeuroPace mit Overweight und einem Kursziel von 18 USD neu auf

06:38 AM EDT, 18.09.2026 (MT Newswires) -- NeuroPace (NPCE) hat laut von FactSet befragten Analysten ein durchschnittliches Rating von Kaufen und ein

MT Newswires 23.07.2026 13:39 Uhr

Mizuho Securities nimmt NeuroPace mit Outperform-Rating und Kursziel von 22 US-Dollar neu in die Analyse auf

07:38 AM EDT, 07/23/2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid

MT Newswires 29.05.2026 14:45 Uhr

NeuroPace sagt, US FDA genehmigt ECoG Assistant zur Verbesserung der Epilepsie-Ergebnisse

08:43 AM EDT, 05/29/2026 (MT Newswires) -- NeuroPace (NPCE) sagte am Freitag, dass die US Food and Drug Administration ihre KI-gesteuerte, von Klinike